REG - Caledonia Investmnts - Net Asset Value(s)

Caledonia InvestmentsAnnouncement

07/05/2026 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260507:nRSG4139Da&default-theme=true

RNS Number : 4139D  Caledonia Investments PLC  07 May 2026

 

Caledonia Investments plc

 

Unaudited net asset value per share at 30 April 2026

 

Caledonia Investments plc ("Caledonia") announces that its unaudited diluted
net asset value per share ("NAV") as at 30 April 2026, calculated on a
cum-income basis, was 574.0p.

 

Performance highlights:

·    NAV total return ("NAVTR") for the month was 1.1% and portfolio
return was 1.1% (2.9% excluding foreign exchange movements). Foreign exchange
resulted in a decrease in net assets of £50m

·    Annualised NAVTR was 9.4% and 9.8% over 10 and five years
respectively

·    £12m of capital and interest was returned from our investment in
Butcombe Group

·    £8m of ordinary shares were repurchased for cancellation during
April at a weighted average discount of 38% resulting in 0.9p accretion to NAV
per share

 

Caledonia's factsheet for the month of April 2026, is available here
(https://www.caledonia.com/shareholder-centre/factsheets/) . The audited
results for the year ended 31 March 2026 will be announced on 19 May 2026.

 

Enquiries

 

 Company contacts
 Caledonia Investments plc  +44 20 7802 8080
 Mat Masters

 Chief Executive Officer

 Rob Memmott

 Chief Financial Officer

 Media contacts
 Teneo                      +44 20 7353 4200
 Tom Murray

 Robert Yates

 caledonia@teneo.com

 

7 May 2026

 

END

 

The monthly reported NAV per share, together with performance statistics and
information on the valuation of principal investments, is available on
Caledonia's website at www.caledonia.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVUPUACAUPQUBM



            Copyright 2019 Regulatory News Service, all rights reserved